IS8753A - Composition comprising cholesterol uptake inhibitor, HMG-CoA reductase inhibitor and binder - Google Patents

Composition comprising cholesterol uptake inhibitor, HMG-CoA reductase inhibitor and binder

Info

Publication number
IS8753A
IS8753A IS8753A IS8753A IS8753A IS 8753 A IS8753 A IS 8753A IS 8753 A IS8753 A IS 8753A IS 8753 A IS8753 A IS 8753A IS 8753 A IS8753 A IS 8753A
Authority
IS
Iceland
Prior art keywords
inhibitor
hmg
binder
composition
coa reductase
Prior art date
Application number
IS8753A
Other languages
Icelandic (is)
Inventor
Philip Wing-Kee
Original Assignee
Merck Sharp & Dohme Limited
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/022889 external-priority patent/WO2004010993A1/en
Application filed by Merck Sharp & Dohme Limited, Schering Corporation filed Critical Merck Sharp & Dohme Limited
Publication of IS8753A publication Critical patent/IS8753A/en

Links

IS8753A 2002-07-26 2008-07-28 Composition comprising cholesterol uptake inhibitor, HMG-CoA reductase inhibitor and binder IS8753A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38969102P 2002-07-26 2002-07-26
PCT/US2003/022889 WO2004010993A1 (en) 2002-07-26 2003-07-22 Composition comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent

Publications (1)

Publication Number Publication Date
IS8753A true IS8753A (en) 2008-07-28

Family

ID=39944599

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8753A IS8753A (en) 2002-07-26 2008-07-28 Composition comprising cholesterol uptake inhibitor, HMG-CoA reductase inhibitor and binder

Country Status (1)

Country Link
IS (1) IS8753A (en)

Similar Documents

Publication Publication Date Title
IS7637A (en) Composition comprising cholesterol uptake inhibitor, HMG-COA reductase inhibitor and binder
ATE286049T1 (en) PYRIDAZINONALDOSE REDUCTASE INHIBITORS
ZA200700351B (en) Compounds, compositions and methods
IS7520A (en) Pyrimidinone Compounds, Compositions and Methods
AU2003262747A8 (en) Compounds, compositions, and methods
EP1556357A4 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
EP1542699A4 (en) Compounds, compositions, and methods employing same
AU2003270015A8 (en) Compounds, compositions, and methods
IL226339B (en) C5 binding aptamers, compositions comprising same and uses thereof
EP1587424A4 (en) HEMOSTATIC COMPOSITIONS AND USES THEREFOR
IL182765A0 (en) Pyridazine compounds, compositions and methods
AU2003299612A8 (en) Compounds, compositions and methods
AU2003288133A8 (en) Herbidical composition
IL164581A0 (en) Compounds, compositions and methods
EP1684754A4 (en) Hmg-coa reductase inhibitors and method
AU2003277079A8 (en) Compounds, compositions, and methods
ZA200606176B (en) Novel Hydroxy-6-heteroarylphenanthridines and their as PDE4 inhibitors
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
AU2003290507A8 (en) Compounds, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
GB0216154D0 (en) Metal chelates
AU2003300031A8 (en) Compounds, compositions, and methods
EP1554265A4 (en) Compounds, compositions and methods
GB0417036D0 (en) Compounds, compositions and devices